SuperSonic Imagine Reports Revenue of €6.4 Million in the Third Quarter of 2019, up +20%

  • Very solid performance for product sales in Q3 (+26%)
  • In Q3, very strong growth in France (+124%) and the United States (+50%), solid sales momentum in China (+15%)
  • Solid growth in 9-month sales to September 30: +10% to €18.2 million
  • Tender offer on SuperSonic Imagine shares open until November 13 inclusive at a price of 1.50 euros per share

AIX-EN-PROVENCE, France--()--Regulatory News:

SuperSonic Imagine (Paris:SSI) (Euronext, FR0010526814 - SSI - PEA-PME eligible), a company specialized in ultrasound medical imaging (ultrasound), today announces its revenue for the third quarter and first 9 months of the year to September 30, 2019.

Michèle Lesieur, Chief Executive Officer of SuperSonic Imagine, says: “I’ am very pleased with the sales performances we recorded last quarter, with very good growth in France and the United States. For its part, China – SuperSonic Imagine’s first growth driver – is continuing to record double-digit growth quarter after quarter. Moreover, Supersonic Imagine’s acquisition project is progressing with the opening of the tender offer from the Hologic group until November 13. I firmly believe that this acquisition project will allow the Company to have the necessary resources to accelerate its growth and strengthen its leadership in terms of innovations in the field of medical imaging”.

 In thousand of euros

2019 

2018 

Change (%) 

Products

5,122

4,213

+22%

% of total sales

85%

84%

 

Services

916

817

+12%

% of total sales

15%

16%

 

1st quarter sales

6,038

5,030

+20%

Products

4,783

5,274

-9%

% of total sales

83%

86%

 

Services

972

877

+11%

% of total sales

17%

14%

 

2nd quarter sales

5,754

6,150

-6%

Products

5,498

4,375

+26%

% of total sales

85%

81%

 

Services

950

1,003

-5%

% of total sales

15%

19%

 

3rd quarter sales

6,448

5,378

+20%

Products

15,403

13,862

+11%

% of total sales

84%

84%

 

Services

2,837

2,696

+5%

% of total sales

16%

16%

 

9-month sales

18,240

16,558

+10%

Other revenue (*)

241

32

 

Total 9-month revenue

18,481

16,590

+11%

Unaudited data. NB (*): this revenue is non recurrent by nature and is not part of the Company’s core business.

Q3 2019 revenue

In the third quarter of 2019, the Company generated revenue of €6,448 thousand, compared with €5,378 thousand in the third quarter of 2018, giving growth of +20%.
Product sales recorded very strong growth (+26%) following the successful launch of the Aixplorer MACH 30 platform among two of our three key markets.

More specifically on its target markets, China is continuing to record solid growth with sales increasing by +15% to €3,237 thousand, vs. €2,818 thousand in Q3 2018. As a reminder, Aixplorer MACH 30 is not yet marketed in China because of the time required to obtain regulatory certification on that market.

France and the United States, markets on which the new platform is being marketed, generated extremely satisfying performances with buoyant sales growth. In France, Q3 sales more than doubled to €878 thousand (+124%). In the United States, following two quarters below expectations, sales were up +50% and totaled €1,072 thousand in Q3 2019 compared with €714 thousand in Q3 2018.

Services sales were stable compared to the two previous quarters at €950 thousand, down 5% compared with the same quarter last year.

Revenue for the first nine months of 2019

Over the first nine months of 2019, SuperSonic Imagine recorded a +10% increase in revenue to €18,240 thousand (vs. €16,558 thousand). At constant currency, revenue was up +6%.

Product sales totaled €15,403 thousand vs. €13,862 thousand, giving growth of +11%, while Services sales increased by +5% to €2,837 thousand.

Altogether, the Company’s three key markets generated revenue of €13,922 thousand, up +23%, driven by the solid performances recorded in China (+31%) and France (+28%).

Across all regions, Asia recorded sales growth of +20% and EMEA +5%. After a disappointing first half, the Americas saw sales fall -12% over the first nine months of the year.

About SuperSonic Imagine
SuperSonic Imagine is a medical technology company (Medtech) specialized in ultrasound imaging. The company designs, develops and markets an ultrasound platform whose exclusive ultrafast technology (UltraFast™) has given rise to new imaging methods, which have now become standards in the non-invasive care path for the characterization of breast, liver or prostate diseases. The first innovative mode UltraFast™ is ShearWave® elastography (SWE™), which allows doctors to instantly visualize and analyze tissue hardness, which is critical information for the diagnosis of many pathologies. To date, more than 600 publications have validated the benefits of its technologies. The latest addition to the Aixplorer® range, Aixplorer MACH® 30 introduces a new generation of imaging UltraFast™ allowing the optimization of all innovative imaging modes: ShearWave PLUS, UltraFast Doppler, Angio PL.U.S, TriVu. With more than 2,300 ultrasound platforms installed worldwide, SuperSonic Imagine is present in more than 80 countries and its main markets are China, the United States and France. The group's revenues for the 2018 financial year amounted to €24.6 million. SuperSonic Imagine is a company listed on Euronext (symbol: SSI).

For more information, visit www.supersonicimagine.fr.

Contacts

FP2COM
Media Relations - EU
Florence Portejoie
fportejoie@fp2com.fr
+33 6 07 76 82 83

NewCap
Investor Relations – EU
Thomas Grojean / Nicolas Merigeau
supersonicimagine@newcap.eu
+33 1 44 71 98 55

Contacts

FP2COM
Media Relations - EU
Florence Portejoie
fportejoie@fp2com.fr
+33 6 07 76 82 83

NewCap
Investor Relations – EU
Thomas Grojean / Nicolas Merigeau
supersonicimagine@newcap.eu
+33 1 44 71 98 55